Abstract 450: JZY-2233: An antigen-targeted CBP/p300 degrader-antibody conjugate for advanced prostate cancer therapy.
Year: 2026
Type: conference-abstract
Source: Cancer Research
Institution: University of Michigan
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7148627477
Cites:
Cited by:
Related to: